Sleep-related problems of Parkinson's disease

Age and Ageing
V DhawanK Ray Chaudhuri

Abstract

To define the epidemiology, characteristics and aetiology of nocturnal symptoms and sleep disorders in patients with Parkinson's disease (PD) and evaluate the available methods for their diagnosis and management. A review of the English-language literature pertaining to sleep disturbances associated with PD, using the Medline database and bibliographies in relevant articles. Sleep-related problems specific to PD may occur early and even predate the diagnosis of the disease but are generally more frequent and more severe in patients with advanced PD. These problems can seriously compromise patients' quality of life and lead to impaired functioning in daily activities. Scales designed specifically for the assessment of sleep problems in patients with PD have recently been developed. Evidence base for the treatment of sleep disturbances in PD is poor, and only nocturnal akinesia, excessive day-time sleepiness and rapid eye movement behaviour disorder have been partially addressed. Sleep disorders associated with PD are a common and under-recognised problem. The assessment of sleep should be part of the routine evaluation of patients with PD, and large-scale controlled therapeutic trials are necessary.

Associated Clinical Trials

Apr 19, 2011·Aleksandar Videnovic, Aleksandar Videnovic

References

Dec 1, 1988·Clinical Neuropharmacology·A J LeesV L Campbell
Jan 1, 1993·Journal of Neural Transmission. Parkinson's Disease and Dementia Section·J J van HiltenR A Roos
Mar 1, 1996·Movement Disorders : Official Journal of the Movement Disorder Society·A TanS Fahn
Dec 17, 1997·Movement Disorders : Official Journal of the Movement Disorder Society·K R ChaudhuriJ D Parkes
Mar 26, 1999·Movement Disorders : Official Journal of the Movement Disorder Society·K KarlsenK Jørgensen
Dec 10, 1999·Movement Disorders : Official Journal of the Movement Disorder Society·E TandbergK Karlsen
Jan 1, 2000·Lancet·S NishinoE Mignot
Apr 7, 2000·Movement Disorders : Official Journal of the Movement Disorder Society·C W OlanowT Roth
Apr 25, 2000·Lancet·J J FerreiraO Rascol
Nov 24, 2001·Trends in Neurosciences·C B SaperT E Scammell
Apr 10, 2002·Neurology·I ArnulfY Agid
May 2, 2002·The Journal of Neuropsychiatry and Clinical Neurosciences·James Parkinson
Oct 3, 2002·Movement Disorders : Official Journal of the Movement Disorder Society·Giovanni FabbriniGiuseppe Meco
Nov 20, 2002·Journal of Neurology, Neurosurgery, and Psychiatry·K R ChaudhuriC Trenkwalder
Dec 25, 2002·Neurobiology of Aging·Heiko BraakEva Braak
Mar 7, 2003·Movement Disorders : Official Journal of the Movement Disorder Society·Charles H AdlerJudy Tiede
Mar 12, 2003·Sleep Medicine Reviews·Diego Garcia-BorregueroMauricio Bravo
Sep 25, 2003·Neurology·K Ray Chaudhuri
Nov 14, 2003·The New England Journal of Medicine·Paul KrackPierre Pollak
Nov 26, 2003·Neurology·M L FantiniJ Montplaisir
Jan 30, 2004·Sleep·Johan MarinusAnne Margarethe Stiggelbout
Feb 24, 2004·Movement Disorders : Official Journal of the Movement Disorder Society·Niels HjortErik Dupont
Mar 9, 2005·Neurology·Maria Livia FantiniJacques Montplaisir
Apr 9, 2005·Movement Disorders : Official Journal of the Movement Disorder Society·Christopher G GoetzCristina Sampaio
Jul 12, 2005·Movement Disorders : Official Journal of the Movement Disorder Society·Nico J DiederichMarc Schlesser
Aug 9, 2005·Sleep Medicine·Glenna A DowlingMichael J Aminoff

❮ Previous
Next ❯

Citations

Jan 23, 2013·Journal of Neural Transmission·Antonia Maass, Heinz Reichmann
Nov 4, 2011·Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·M T PellecchiaP Barone
Feb 9, 2012·Current Neurology and Neuroscience Reports·Qiuping Pearl ZhouKathy C Richards
Jun 27, 2008·Current Treatment Options in Neurology·Cynthia L Comella
Jun 14, 2013·Age and Ageing·Marcos Hortes N ChagasJosé Alexandre S Crippa
Mar 16, 2011·American Journal of Epidemiology·Jianjun GaoHonglei Chen
Nov 29, 2007·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·B PorterR Walker
Mar 1, 2011·Therapeutic Advances in Chronic Disease·Steven Wishart, Graeme J A Macphee
Jun 17, 2009·Reviews in the Neurosciences·Nirinjini Naidoo
Feb 18, 2011·CNS Drugs·Bettina KnieK Ray Chaudhuri
Jun 27, 2014·PloS One·Philipp O ValkoChristian R Baumann
Jul 10, 2010·The International Journal of Neuroscience·Jim BarnesKsenija Maravic
Oct 22, 2013·Expert Opinion on Pharmacotherapy·Angelo AntoniniManuela Pilleri
Mar 6, 2007·Expert Opinion on Drug Delivery·Y Naidu, K Ray Chaudhuri
Apr 2, 2010·Neurologia i neurochirurgia polska·Adam StepieńMarta Durka-Kesy
Jun 5, 2012·Journal of the Neurological Sciences·Katerina FarnikovaPetr Kanovsky
Aug 18, 2010·Experimental Neurology·Kimberly A McDowellJessica A Mong
Apr 14, 2009·Parkinsonism & Related Disorders·M I NorlinahA A Raymond
Apr 21, 2009·Lancet Neurology·K Ray Chaudhuri, Anthony H V Schapira
Feb 13, 2009·Parkinsonism & Related Disorders·Regina MargisCarlos R M Rieder
Mar 29, 2008·Journal of the Neurological Sciences·Eva HavlikovaJohan W Groothoff
May 9, 2009·Movement Disorders : Official Journal of the Movement Disorder Society·Holger HonigK Ray Chaudhuri
Nov 8, 2008·Annals of the New York Academy of Sciences·Shen-Yang LimJanis M Miyasaki
Jan 8, 2009·Annals of Neurology·Andrew Siderowf, Matthew B Stern
Nov 13, 2007·Movement Disorders : Official Journal of the Movement Disorder Society·Sean S O'SullivanAndrew J Lees
Feb 17, 2010·International Journal of Geriatric Psychiatry·Iracema LeroiE Jane Byrne
Jul 16, 2010·Movement Disorders : Official Journal of the Movement Disorder Society·Marios PolitisPaola Piccini
Feb 1, 2013·Neuropathology and Applied Neurobiology·M E KalaitzakisR K B Pearce
Jun 24, 2015·Journal of Cognitive Neuroscience·John GroganElizabeth Coulthard
May 11, 2016·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·L KlingelhoeferK R Chaudhuri
Jun 1, 2016·Frontiers in Aging Neuroscience·Isobel T French, Kalai A Muthusamy
Jul 4, 2016·Clinical Neurology and Neurosurgery·Shweta PandeyKuljeet Singh Anand
Nov 5, 2016·Parkinsonism & Related Disorders·Lukas EugsterW M Michael Schuepbach
Oct 20, 2011·Therapeutic Advances in Neurological Disorders·Venkatramanujam SrinivasanSeithikurippu R Pandi-Perumal
Feb 24, 2017·Annals of the American Thoracic Society·Shirin ShafazandCarlos Singer
Oct 28, 2016·Journal of Strength and Conditioning Research·Carla Silva-BatistaCarlos Ugrinowitsch
Dec 7, 2017·Acta neurologica Belgica·Bruno T JunhoNatalia P Rocha
Mar 2, 2018·Journal of Sleep Research·Susanna MantovaniJohn D O'Sullivan

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.